肌注黄体酮优化程序化冻胚移植的活产率:一项随机临床试验
该多中心三臂随机对照非劣效试验纳入1125例计划移植高质量非活检囊胚的受试者,比较每日肌注黄体酮、阴道微粒化黄体酮联合每三日肌注黄体酮、单用阴道微粒化黄体酮三种内膜准备方案。共完成1060次冻胚移植,单用阴道黄体酮组活产率(27%)显著低于肌注组(44%)和联合组(46%),且单用阴道组50%妊娠以流产告终。联合方案非劣效于每日肌注,且注射次数更少。
要点
- 单用阴道黄体酮组活产率27%,显著低于肌注组44%和联合组46%。
- 单用阴道黄体酮组50%妊娠以流产告终。
- 阴道黄体酮联合每三日肌注非劣效于每日肌注,注射更少。
核心结论
- 单用阴道黄体酮替代的活产率显著降低,主要因流产率增加。
- 阴道黄体酮联合每三日肌注黄体酮非劣效于每日肌注,是有效替代方案且注射次数更少。
研究设计与样本
- 三臂、随机、对照非劣效试验,多中心生殖门诊开展。
- 筛选1346例计划移植高质量非活检玻璃化 warmed 囊胚的志愿者,最终入组1125例并随机分组。
- 干预为冻胚移植内膜准备:每日肌注黄体酮50 mg(对照组)、阴道微粒化黄体酮200 mg每日两次联合每三日肌注黄体酮50 mg(联合组)、或阴道微粒化黄体酮200 mg每日两次(单用阴道组)。
- 主要结局为每移植周期的活产率;次要结局包括移植后2周血清hCG阳性、生化妊娠丢失、临床妊娠、临床妊娠丢失、总妊娠丢失、移植后2周血清黄体酮浓度及患者对给药途径的体验与态度调查。
- 共完成1060次冻胚移植。
主要发现
- 单用阴道黄体酮组活产率27%,显著低于肌注组44%和联合组46%。
- 单用阴道黄体酮组50%妊娠以流产告终。
临床怎么用
- 程序化冻胚移植内膜准备应避免单用阴道黄体酮,因其活产率显著降低且流产率增加。
- 可考虑阴道黄体酮联合每三日肌注黄体酮作为每日肌注的非劣效替代方案,以减少注射次数。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether vaginal progesterone for programmed endometrial preparation is noninferior to intramuscular progesterone in terms of live birth rates from frozen embryo transfer (FET). DESIGN: Three-armed, randomized, controlled noninferiority trial. SETTING: Multicenter fertility clinic. PATIENT(S): A total of 1,346 volunteer subjects planning vitrified-warmed transfer of high-quality nonbiopsied blastocysts were screened, of whom 1,125 subjects were ultimately enrolled and randomly assigned to treatment. INTERVENTION(S): The subjects were randomly assigned to receive, in preparation for FET, 50 mg daily of intramuscular progesterone (control group), 200 mg twice daily of vaginal micronized progesterone plus 50 mg of intramuscular progesterone every third day (combination treatment), or 200 mg twice daily of vaginal micronized progesterone. MAIN OUTCOME MEASURE(S): The primary outcome was live birth rate per vitrified-warmed embryo transfer. The secondary outcomes were a positive serum human chorionic gonadotropin test 2 weeks after FET, biochemical pregnancy loss, clinical pregnancy, clinical pregnancy loss, total pregnancy loss, serum luteal progesterone concentration 2 weeks after FET, and patient's experience and attitudes regarding the route of progesterone administration, on the basis of a survey administered to the subjects between FET and pregnancy test. RESULT(S): A total of 1,060 FETs were completed. The live birth rate was significantly lower in women receiving only vaginal progesterone (27%) than in women receiving intramuscular progesterone (44%) or combination treatment (46%). Fifty percent of pregnancies in women receiving only vaginal progesterone ended in miscarriage. CONCLUSION(S): The live birth rate after vaginal-only progesterone replacement was significantly reduced, due primarily to an increased rate of miscarriage. Vaginal progesterone supplemented with intramuscular progesterone every third day was noninferior to daily intramuscular progesterone, offering an effective alternative regimen with fewer injections. CLINICAL TRIAL REGISTRATION NUMBER: NCT02254577.
引用
- Devine K, Richter KS, Jahandideh S, et al. Intramuscular progesterone optimizes live birth from programmed frozen embryo transfer: a randomized clinical trial. Fertil Steril. 2021. PMID: 33992421. doi:10.1016/j.fertnstert.2021.04.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。